PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30110942 ↗2018Reported benefit

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway.

MouseChemical/toxinICR (specific pathogen-free)Malen = 40 mice, four groups of 10Oral20 and 40 mg/kg per dayPre-treatment for 7 consecutive days, with the final dose given 1 h before acet…

Model: Acetaminophen-induced acute liver injury, single oral dose of 400 mg/kg acetaminophen, animals sacrificed 4 h later

Astragaloside IV pre-treatment at 20 and 40 mg/kg significantly reduced serum alanine and aspartate aminotransferase, alleviated necrosis and inflammation on histology, restored hepatic glutathione and superoxide dismutase, lowered malondialdehyde, suppressed TNF-alpha, IL-1beta and IL-6, increased…

Extraction: extract · Supplied extraction confidence: 0.94. Machine-extracted fields require source verification.